LS
Lakshmanan Subash
About Lakshmanan Subash
Data last updated:
Lakshmanan Subash is a Director at Crantor Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Crantor Pharmaceuticals Private Limited reported revenue of ₹1.22 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Crantor Pharmaceuticals Private Limited U24299TZ2022PTC038478 | Director | 21 Mar 2022 | 2022 | ₹1.22 Cr (FY 2025) | Active |
Board colleagues of Lakshmanan Subash
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nithiyanandham Karthikeyan | 09541476 | Crantor Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Lakshmanan Subash
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lakshmanan Subash
Lakshmanan Subash currently holds 1 directorship: Crantor Pharmaceuticals Private Limited (Director, since 21 Mar 2022, revenue ₹1.22 Cr (FY 2025)).
Lakshmanan Subash was first appointed on 21 Mar 2022 as Director at Crantor Pharmaceuticals Private Limited.
The current boards of Lakshmanan Subash's companies include Nithiyanandham Karthikeyan (Crantor Pharmaceuticals Private Limited).